{"id":5367,"date":"2026-09-26T04:30:03","date_gmt":"2026-09-26T04:30:03","guid":{"rendered":"https:\/\/www.vaultinsider.top\/?p=5367"},"modified":"2026-09-26T04:30:03","modified_gmt":"2026-09-26T04:30:03","slug":"survey-most-americans-wouldnt-take-glp-1-drugs-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.vaultinsider.top\/?p=5367","title":{"rendered":"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/fortune.com\/img-assets\/wp-content\/uploads\/2024\/10\/GettyImages-2163159680-e1728488327908.jpg?w=2048\" \/><\/p>\n<div>\n<p class=\"wp-block-paragraph\">Yet despite the ubiquitousness of injectable drugs indicated for people with obesity\u2014such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)\u2014most Americans wouldn\u2019t take them, according to a new survey.<\/p>\n<p class=\"wp-block-paragraph\">The nonprofit Physicians Committee for Responsible Medicine teamed up with business intelligence firm Morning Consult to survey more than 2,200 U.S. adults about weight-loss methods. Results of the poll, conducted in September, were released Oct. 8.<\/p>\n<p class=\"wp-block-paragraph\">People were asked to rate their level of agreement with this statement: \u201cIf I wanted to lose weight, I would rather take an injectable weight-loss drug, rather than make a diet change.\u201d More than half (62%) disagreed, with 14% reporting the statement didn\u2019t apply to them because they don\u2019t need to lose weight. Nearly three-fourths (73%) of applicable respondents disagreed.<\/p>\n<p class=\"wp-block-paragraph\">Among people who were interested in weight loss, these groups most strongly disagreed:<\/p>\n<ul class=\"wp-block-list\">\n<li><strong>Men:<\/strong> 75%<\/li>\n<li><strong>Baby boomers: <\/strong>78%<\/li>\n<li><strong>Asian or \u201cother\u201d:<\/strong> 77%<\/li>\n<li><strong>Postgraduate-degree holders:<\/strong> 79%<\/li>\n<li><strong>Household income exceeds $100K: <\/strong>78%<\/li>\n<li><strong>Urban dwellers: <\/strong>75%<\/li>\n<li><strong>Northeasterners: <\/strong>77%<\/li>\n<li><strong>Registered voters: <\/strong>73%<\/li>\n<li><strong>Independent voters:<\/strong> 74%<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\">\u201cThe new findings do not mean that Americans do not want to lose weight,\u201d PCRM president Dr. Neal Barnard said in a news release about the survey. \u201cRather, most would prefer to change their eating habits than inject a medication.\u201d<\/p>\n<p><span\/><\/p>\n<p class=\"wp-block-paragraph\">While the results offer a snapshot of public opinion, the question doesn\u2019t capture the nuances of healthy weight loss. A calorie deficit is a critical component of weight loss but ultimately just one piece of the puzzle. Genes, sleep, stress, hormones, physical activity, and certain medications can impact weight management. Your medical history also plays a role. What\u2019s more, GLP-1s approved for people with obesity are intended for patients who\u2019ve had difficulty losing weight by other means, and designed to be taken in conjunction with diet and exercise.<\/p>\n<p class=\"wp-block-paragraph\">Dr. Nisha Patel, medical director of the Obesity Medicine and Metabolic Health Program within the transplant department at California Pacific Medical Center in San Francisco, is working to dispel the myth that taking weight-loss medication is the easy way out.<\/p>\n<p class=\"wp-block-paragraph\">\u201cPeople forget that there are some strong neurohormonal factors at play that make it difficult to not only lose weight, but to keep that weight off in the long term,\u201d Patel previously told <em>Fortune<\/em>. \u201cMedications have really helped level the playing field. It can help interrupt some of that disruptive signaling.\u201d<\/p>\n<p class=\"wp-block-paragraph\">That said, GLP-1 adherence is an issue. According to a research brief published in the August issue of the <em>Journal of Managed Care and Specialty Pharmacy<\/em><em>,<\/em> roughly one in three (32%) patients were still on their medication after a year. Fewer than that (27%) took the drug as intended.<\/p>\n<h2 class=\"wp-block-heading\">Plant-based diet appeals to weight-loss hopefuls<\/h2>\n<p class=\"wp-block-paragraph\">The PCRM survey also asked people how much they agreed with this statement: \u201cIf a plant-based diet might cause significant weight loss, I would be interested in trying it, at least briefly.\u201d More than half (57%) of all respondents agreed, with 17% saying they didn\u2019t need to lose weight. More than three in five (68%) respondents looking to lose weight agreed.<\/p>\n<p class=\"wp-block-paragraph\">Among people who were interested in weight loss, these groups most strongly agreed:<\/p>\n<ul class=\"wp-block-list\">\n<li><strong>Women: <\/strong>70%<\/li>\n<li><strong>Gen Zers: <\/strong>81%<\/li>\n<li><strong>Asian or \u201cother\u201d:<\/strong> 76%<\/li>\n<li><strong>College and postgraduate-degree holders (tie):<\/strong> 69%<\/li>\n<li><strong>Household income exceeds $100K: <\/strong>70%<\/li>\n<li><strong>Urban dwellers: <\/strong>75%<\/li>\n<li><strong>Northeasterners: <\/strong>70%<\/li>\n<li><strong>Registered voters: <\/strong>69%<\/li>\n<li><strong>Democrats:<\/strong> 76%<\/li>\n<\/ul>\n<p><span\/><\/p>\n<p class=\"wp-block-paragraph\"><strong>For more on weight management:<\/strong><\/p>\n<\/div>\n<p>#Survey #Americans #wouldnt #GLP1 #drugs #weight #loss<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Yet despite the ubiquitousness&hellip; <\/p>\n","protected":false},"author":1,"featured_media":5368,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[1322,1982,930,8264,3499,4416,3634,8437,1031,4709,886,3552,8265,3550,3638,1981,1080,8438,6245,3745,4583,1838,8439,8440,3640,3551,3641,3642,8441,3869],"class_list":["post-5367","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance-news","tag-americans","tag-and-wellness","tag-diet","tag-doctors","tag-drugs","tag-editors-picks","tag-eli-lilly","tag-exercise","tag-fitness","tag-glp1","tag-health","tag-loss","tag-medicine","tag-novo-nordisk","tag-ozempic","tag-personal-health","tag-pharmaceutical-industry","tag-poll","tag-polling","tag-polls","tag-survey","tag-surveys","tag-vegan","tag-veganism","tag-wegovy","tag-weight","tag-weight-loss","tag-weight-loss-and-diet-control-industry","tag-well-migrated","tag-wouldnt"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss - Finance News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vaultinsider.top\/?p=5367\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss - Finance News\" \/>\n<meta property=\"og:description\" content=\"Yet despite the ubiquitousness&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vaultinsider.top\/?p=5367\" \/>\n<meta property=\"og:site_name\" content=\"Finance News\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-26T04:30:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fortune.com\/img-assets\/wp-content\/uploads\/2024\/10\/GettyImages-2163159680-e1728488327908.jpg?w=2048\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/#\\\/schema\\\/person\\\/ed40724a3e5d482ce66781a042c3c31e\"},\"headline\":\"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss\",\"datePublished\":\"2026-09-26T04:30:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367\"},\"wordCount\":550,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vaultinsider.top\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/GettyImages-2163159680-e1728488327908.jpg\",\"keywords\":[\"Americans\",\"and Wellness\",\"Diet\",\"doctors\",\"Drugs\",\"Editor's Picks\",\"Eli Lilly\",\"exercise\",\"fitness\",\"GLP1\",\"Health\",\"loss\",\"medicine\",\"Novo Nordisk\",\"Ozempic\",\"Personal Health\",\"Pharmaceutical Industry\",\"Poll\",\"polling\",\"Polls\",\"survey\",\"Surveys\",\"Vegan\",\"Veganism\",\"Wegovy\",\"Weight\",\"Weight Loss\",\"weight-loss and diet control industry\",\"Well Migrated\",\"wouldnt\"],\"articleSection\":[\"Finance News\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367\",\"url\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367\",\"name\":\"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss - Finance News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vaultinsider.top\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/GettyImages-2163159680-e1728488327908.jpg\",\"datePublished\":\"2026-09-26T04:30:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/#\\\/schema\\\/person\\\/ed40724a3e5d482ce66781a042c3c31e\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#primaryimage\",\"url\":\"https:\\\/\\\/www.vaultinsider.top\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/GettyImages-2163159680-e1728488327908.jpg\",\"contentUrl\":\"https:\\\/\\\/www.vaultinsider.top\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/GettyImages-2163159680-e1728488327908.jpg\",\"width\":1200,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/?p=5367#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/www.vaultinsider.top\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/#website\",\"url\":\"https:\\\/\\\/www.vaultinsider.top\\\/\",\"name\":\"Finance News\",\"description\":\"Just another Finance News site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vaultinsider.top\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vaultinsider.top\\\/#\\\/schema\\\/person\\\/ed40724a3e5d482ce66781a042c3c31e\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.vaultinsider.top\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss - Finance News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vaultinsider.top\/?p=5367","og_locale":"zh_CN","og_type":"article","og_title":"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss - Finance News","og_description":"Yet despite the ubiquitousness&hellip;","og_url":"https:\/\/www.vaultinsider.top\/?p=5367","og_site_name":"Finance News","article_published_time":"2026-09-26T04:30:03+00:00","og_image":[{"url":"https:\/\/fortune.com\/img-assets\/wp-content\/uploads\/2024\/10\/GettyImages-2163159680-e1728488327908.jpg?w=2048","type":"","width":"","height":""}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"admin","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"3 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vaultinsider.top\/?p=5367#article","isPartOf":{"@id":"https:\/\/www.vaultinsider.top\/?p=5367"},"author":{"name":"admin","@id":"https:\/\/www.vaultinsider.top\/#\/schema\/person\/ed40724a3e5d482ce66781a042c3c31e"},"headline":"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss","datePublished":"2026-09-26T04:30:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vaultinsider.top\/?p=5367"},"wordCount":550,"commentCount":0,"image":{"@id":"https:\/\/www.vaultinsider.top\/?p=5367#primaryimage"},"thumbnailUrl":"https:\/\/www.vaultinsider.top\/wp-content\/uploads\/2026\/09\/GettyImages-2163159680-e1728488327908.jpg","keywords":["Americans","and Wellness","Diet","doctors","Drugs","Editor's Picks","Eli Lilly","exercise","fitness","GLP1","Health","loss","medicine","Novo Nordisk","Ozempic","Personal Health","Pharmaceutical Industry","Poll","polling","Polls","survey","Surveys","Vegan","Veganism","Wegovy","Weight","Weight Loss","weight-loss and diet control industry","Well Migrated","wouldnt"],"articleSection":["Finance News"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.vaultinsider.top\/?p=5367#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.vaultinsider.top\/?p=5367","url":"https:\/\/www.vaultinsider.top\/?p=5367","name":"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss - Finance News","isPartOf":{"@id":"https:\/\/www.vaultinsider.top\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vaultinsider.top\/?p=5367#primaryimage"},"image":{"@id":"https:\/\/www.vaultinsider.top\/?p=5367#primaryimage"},"thumbnailUrl":"https:\/\/www.vaultinsider.top\/wp-content\/uploads\/2026\/09\/GettyImages-2163159680-e1728488327908.jpg","datePublished":"2026-09-26T04:30:03+00:00","author":{"@id":"https:\/\/www.vaultinsider.top\/#\/schema\/person\/ed40724a3e5d482ce66781a042c3c31e"},"breadcrumb":{"@id":"https:\/\/www.vaultinsider.top\/?p=5367#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vaultinsider.top\/?p=5367"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.vaultinsider.top\/?p=5367#primaryimage","url":"https:\/\/www.vaultinsider.top\/wp-content\/uploads\/2026\/09\/GettyImages-2163159680-e1728488327908.jpg","contentUrl":"https:\/\/www.vaultinsider.top\/wp-content\/uploads\/2026\/09\/GettyImages-2163159680-e1728488327908.jpg","width":1200,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.vaultinsider.top\/?p=5367#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/www.vaultinsider.top\/"},{"@type":"ListItem","position":2,"name":"Survey: Most Americans wouldn\u2019t take GLP-1 drugs for weight loss"}]},{"@type":"WebSite","@id":"https:\/\/www.vaultinsider.top\/#website","url":"https:\/\/www.vaultinsider.top\/","name":"Finance News","description":"Just another Finance News site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vaultinsider.top\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/www.vaultinsider.top\/#\/schema\/person\/ed40724a3e5d482ce66781a042c3c31e","name":"admin","url":"https:\/\/www.vaultinsider.top\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=\/wp\/v2\/posts\/5367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5367"}],"version-history":[{"count":0,"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=\/wp\/v2\/posts\/5367\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=\/wp\/v2\/media\/5368"}],"wp:attachment":[{"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vaultinsider.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}